Neurocrine Biosciences shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Ensign Peak Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $25M | 180k | 140.38 |
| 2025-06-30 | $22M | 171k | 125.69 |
| 2025-03-31 | $22M | 195k | 110.60 |
| 2024-12-31 | $24M | 174k | 136.50 |
| 2024-09-30 | $20M | 175k | 115.22 |
| 2024-06-30 | $38M | 273k | 137.67 |
| 2024-03-31 | $21M | 155k | 137.92 |
| 2023-09-30 | $9.6M | 85k | 112.50 |
| 2023-06-30 | $9.0M | 96k | 94.30 |
| 2023-03-31 | $6.9M | 68k | 101.22 |
| 2022-12-31 | $6.2M | 52k | 119.44 |
| 2022-09-30 | $4.7M | 44k | 106.19 |
| 2022-06-30 | $6.0M | 62k | 97.49 |
| 2022-03-31 | $6.2M | 66k | 93.76 |
| 2021-12-31 | $6.1M | 72k | 85.16 |
| 2021-09-30 | $10M | 107k | 95.91 |
| 2021-06-30 | $11M | 109k | 97.32 |
| 2021-03-31 | $4.7M | 49k | 97.27 |
| 2020-12-31 | $17M | 175k | 95.85 |
| 2020-09-30 | $20M | 208k | 96.16 |
| 2020-06-30 | $16M | 132k | 122.00 |
| 2020-03-31 | $8.0M | 93k | 86.56 |
| 2019-12-31 | $12M | 111k | 107.49 |